These interactions seem to be crucial for translation as mutations in the N-terminal tail of eIF1A, which are frequently observed in several types of cancers [105], result in reduced binding of eIF1A to its r-protein partners and a hyperaccurate recognition of AUG codons that are embedded in an optimal sequence context [106,107]. This evidence concerns the gene EIF1 and cancer.